PBMs

Market Access

$100 notes in pill bottle on aquamarine background with spilled pills

How new PBM transparency rules will alter drug pricing

The complex drug pricing ecosystem means all stakeholders are scrambling to understand how the new regulations and PBMs’ adjustments will impact them.

News

Business Group on Health statistics graphic

As drug costs for US employers rise, some cut GLP-1s from pl...

Pharmacy now represents 25% of employer healthcare spending, and employers are turning to DTC models and non-traditional PBMs to cut costs.

Market Access

pharmaphorum podcast Episode 210 - Neal Masia

Smoothing a contract pathway through uncertainty: In convers...

Today's podcast with Entity Risk's Neal Masia includes insights on the 340B Program, PBMs, and risk-based contracts.

Market Access

Beyond the Bill: how do we make medicines affordable without...

Two pharmaceutical giants have paused investment in the UK. More than a setback for British life sciences, it’s a warning sign for the future.

Patients

Mapping the crisis: How data can help fix America’s growing ...

As major pharmacy chains like Walgreens continue to close hundreds of stores nationwide, pharmacy deserts are increasing across the US.

R&D

How new PBM transparency rules will alter drug pricing

As drug costs for US employers rise, some cut GLP-1s from pl...

Smoothing a contract pathway through uncertainty: In convers...

Beyond the Bill: how do we make medicines affordable without...

Mapping the crisis: How data can help fix America’s growing ...

Insights from JP Morgan 2025: Key trends shaping the pharma ...

Iambic prices its IPO, seeking to raise up to $160m

Discover a new era of healthcare panel engagement: Grounded ...

PBMs

Editor's Picks